The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Letter to Board of Lekoil Limited

1 Nov 2021 07:00

RNS Number : 8233Q
Lekoil Nigeria Limited
01 November 2021
 

 

01 November 2021

 

Lekoil Nigeria Limited

("Lekoil Nigeria")

 

Letter to Board of Lekoil Limited

 

LAGOS, Nigeria. 01 November 2021

 

Lekoil Nigeria Limited, the oil and gas exploration and production company with a focus on Nigeria and West Africa, in which Lekoil Limited (AIM: LEK) has a 40% equity interest, has been requested by the signatories of a letter, sent to the Board of Lekoil Limited on 29th October 2021, to publish the letter on their behalf.

 

The letter, which appears at the link below, sets out a number of concerns regarding the intentions of the Board of Lekoil plc which, if correct, would be to the detriment of shareholders.

 

The directors of Lekoil Nigeria have informed the Board of Lekoil Nigeria that, unless a satisfactory response is received immediately, they will initiate requisite steps to enforce the interests of all minority shareholders.

 

All of the signatories are shareholders in Lekoil Limited.

http://www.rns-pdf.londonstockexchange.com/rns/8233Q_1-2021-11-1.pdf 

 

 

For further information, please contact:

LEKOIL Nigeria Limited

Hamilton Esi, Corporate Communications

+2348106421047

media@lekoil.com

 

 

-end-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUAORRAOUARRA
Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.